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Case report
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Careful examination of the tegument may provide im-
portant diagnostic clues in patients developing compli-
cations after liver transplantation.
Case report
Our patient was diagnosed with Crohn’s disease at the
age of 22 and underwent orthotopic liver transplanta-
tion 14 years later for endstage primary sclerosing
cholangitits. The immediate postoperative course was
uneventful and the patient was discharged on the ninth
postoperative day. Two months after transplantation,
steroids had to be reintroduced for histologically
proven rejection, and cyclosporin was replaced by
tacrolimus.
Four years after the transplantation, the patient suf-
fered from a severe exacerbation of his inflammatory
bowel disease. This flare did not respond to steroids,
and the patient underwent a subtotal colectomy. He
recovered quickly from surgery. One month later, he
declined a liver biopsy, which was indicated for a
moderate elevation of serum aminotransferase levels.
Prednisone therapy for acute rejection was empirically
started (600mg for 3 days, then 40 mg/day) in addition
to his immunosuppressive regimen (tacrolimus and aza-
thioprine). The liver test results normalized. Then, he
consulted his physician for ulcerated phimosis. Doxy-
cycline was prescribed, but was without effect. A few
days later, the patient developed stomatitis, which was
interpreted as oral candidiasis and was treated with
fluconazole. One day before hospitalization the patient
developed fever and skin lesions on both hands. He
appeared in the emergency room with a 38.5°C fever
and in a severely diminished nutritional status. He had
no pain, but complained of polydipsia and pollakiuria.
Both hands had multiple vesicular and pustular lesions.
He had several ulcerations on the soft and hard palate,
as well as on the tongue. Genital examination revealed
If not promptly recognized and treated, herpes simplex
virus (HSV) hepatitis is associated with a high mortal-
ity. A patient transplanted for primary sclerosing
cholangitis required, 4 years later, a colectomy for
a steroid-resistant flare of ulcerative colitis. He
subsequently developed fever, with genital and oral
ulcerations. He was hospitalized for diabetic decompen-
sation with massive elevation of serum amino-
transferases. Examination revealed vesicles on the
hands. Liver biopsy showed Cowdry type B inclusions.
Therapy with acyclovir was immediately initiated and
the patient recovered. This case illustrates the diagnos-
tic importance of mucocutaneous lesions in the assess-
ment of complications after liver transplantation.
Key words: herpes simplex, hepatitis, orthotopic liver
transplantation, immunosuppression
Introduction
Herpes simplex virus (HSV) is a ubiquitous virus which
usually infects mucocutaneous epithelial and neuronal
cells. Rarely, HSV disseminates to infect other cell
types, such as hepatocytes, leading to severe parenchy-
mal damage. It is crucial to recognize and treat HSV
hepatitis without delay to improve its dismal outcome.
We discuss a patient hospitalized 4 years after liver
transplantation for rapidly developing severe hepatitis.
The presence of vesicles on the hands, as well as genital
and oral ulcerations, raised the suspicion of HSV infec-
tion. A liver biopsy confirmed the dissemination of the
infection. The patient recovered with antiviral therapy.
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coalescent ulcerations on the foreskin, with phimosis
(Fig. 1). He was not jaundiced and his liver was not
enlarged. Duplex-sonography of the liver was normal.
Blood examination revealed a decreased white blood
cell count (2500/mm3) and pronounced lymphocytope-
nia (0.100/mm3). Serum aspartate aminotransferase and
alanine aminotransferase levels were 1272 and 843U/l,
respectively (Fig. 2). Serum alkaline phosphatase and
γ-glutamyltransferase levels were 142 U/l and 413U/l.
Albumin was reduced to 23g/l, and the international
normalized ratio (INR) was 1.1. Blood glucose concen-
tration was elevated to 55.3 mM. Creatinine was 200µM
and the serum tacrolimus level was dramatically in-
creased (80.5 ng/ml). Therapy for diabetic decompensa-
tion was started, and a transjugular liver biopsy was
performed. Histology revealed several large, rounded,
and rather well-delineated foci of coagulative parenchy-
mal necrosis, with disintegration of liver cell plates and
accumulation of nuclear debris (Fig. 3A). At the edge of
the necrotic zones, several hepatocytes exhibited nuclei
with amphophilic viral inclusions lacking a peripheral
halo (Cowdry type B inclusions; Fig. 3A). Immuno-
histochemically, decayed hepatocytes within the ne-
crotic areas and intact cells at their edges were reactive
for HSV-1 antigen, with both a nuclear and a cytoplas-
mic staining pattern (Fig. 3B). There were no histolo-
gical signs of rejection. Intravenous therapy with
acyclovir (10 mg/kg body weight/12h) was immediately
started. Cultures from smears of mouth and foreskin
were positive for HSV type 1 virus. Hepatitis A, B, and
C, as well as Epstein-Barr virus and cytomegalovirus
serologies were negative. Complement fixation test for
HSV was positive; the same test had been negative
Fig. 1A–C. Mucocutaneous lesions.
A Coalescent ulcerations of the fore-
skin with phimosis. B Numerous
vesicular and pustular lesions on the
right hand. C Vesicular lesions on the
lips, and ulcerations of the tongue
Fig. 2. Synopsis of selected laboratory values during hospital-
ization. Values on the y-axis show aspartate aminotransferase
(ASAT) and alanine aminotransferase (ALAT), in U/l, C-
reactive protein (CRP), in mg/l, multiplied by a factor of 10.
The international normalized ratio (INR) is multiplied by a
factor of 1000 and the white blood cell count (WBC) is per
mm3, divided by a factor of 10. Arrows indicate the time of
biopsy and the initiation of the acyclovir treatment. The x-axis
represents the time; each bar is a week
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6 months earlier, supporting the notion of a primary
infection. 5 The blood parameters improved (Fig. 2)
and, after a few days, the lesions in the mouth and on
the hands began to disappear. The patient underwent
circumcision under local anesthesia. Two weeks later,
the intravenous acyclovir therapy was stopped and he
was discharged in good condition 19 days after admis-
sion. Five weeks after discharge, insulin therapy could
be stopped.
Discussion
HSV hepatitis is rare in healthy individuals,1–3 pregnant
women,4–6 and neonates.7,8 The majority of reports con-
cern immunosuppressed patients, particularly recipients
of solid organ transplantation.9–14 Kusne and cowork-
ers10 found that HSV hepatitis mostly occurred early
after organ transplantation. Compared to the relatively
frequent cytomegalovirus infection, which peaks 30–40
days after transplantation, HSV hepatitis can occur as
early as 5 days after liver transplantation, with a median
of 18 days. These series had a high mortality; three of
four patients with a primary infection, and five of eight
patients with a reactivation died. The risk of a fulminant
course was three times higher in primary infection
(75%) than in reactivation (25%). Our patient suffered
from a primary infection, because HSV serologies and
hepatic immunochemistry for HSV-1 antigen were
negative on several occasions prior to this infection.
Blood analysis of the donor revealed IgG antibodies
against HSV type 1. Transmission of HSV through
a transplant is possible.11,12 However, transmission
through the transplanted organ several years after
transplantation is unlikely.10 This patient was particu-
larly immunosuppressed. He required several pred-
nisone courses, the last one 6 weeks before admission.
The development of HSV hepatitis after the use of
steroids has been described.15 One case report describes
a primary infection with HSV-1 in a young patient with
inflammatory bowel disease treated with 40 mg pred-
nisone once a day,16 a situation comparable to the one
reported here, but with a fatal outcome.
Our patient presented not only with severe hepatitis
but also with diabetic decompensation. He had received
a higher dose of steroids before without requiring
insulin, suggesting that this episode was probably not
steroid-induced. It may have been due to an infection of
the pancreatic  cells by the HSV. HSV can occasionally
disseminate to the pancreas, but we could not find
literature documenting HSV-induced diabetes mellitus.
We favor, as an explanation, toxicity of tacrolimus,
which reached high concentrations due to the hepatitis.
Immunosuppressive drugs such as cyclosporin A and
tacrolimus, which act by inhibiting the phosphatase ac-
tivity of calcineurin, also impair the regulation of insulin
secretion by  cells.17
Several authors emphasize the importance of the
early diagnosis and treatment of herpes simplex hepati-
tis.18,19 Yet early diagnosis can be difficult. A recent
literature review showed that only 27% of patients had
oral lesions; 31% had genital lesions; and only 4% (two
patients) presented with both types of lesions, as in our
patient.20 A liver biopsy should be quickly organized.
Acyclovir is the drug of choice for herpes hepatitis, yet
doses and duration of therapy have not been estab-
lished. Intravenous application of 10 mg/kg per 8h in
adjustment of renal function is a reasonable adaptation
from the dose and duration used for the more common
HSV encephalitis.19 In fulminant hepatitis, orthotopic
liver transplantation1,21 or living-donor liver transplan-
tation22 can be considered. Fortunately, due to the rapid
Fig. 3A,B. Histology of liver biopsy specimen. A Fresh coagu-
lative parenchymal necrosis with decay of hepatocytes and
much nuclear debris. Note that some hepatocytes (arrows)
exhibit nuclei with purple homogeneous nuclear inclusions,
corresponding to Cowdry type B inclusions. B Immuno-
staining for herpes simplex virus (HSV)-1 antigen. Most of the
damaged cells within the necrotic zone are reactive (red reac-
tion product), and positivity is even more marked in preserved
hepatocytes at the border (including the nuclear inclusion
bodies). A H&E. A,B Original magnification  40
A
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diagnosis and therapy, our patient fully recovered.
Typical mucocutaneous lesions in liver-transplanted
patients should immediately raise the possibility of
HSV hepatitis.
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